Bellevue F.(L)-B.Obesity Sol.I EUR/ LU0415392678 /
| NAV2024-04-18 | Chg.-2.9000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 688.9000EUR | -0.42% | reinvestment | Equity Worldwide | Waystone M.Co.(Lux) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009 | - | - | - | - | -2.45 | 6.30 | 6.58 | -0.94 | 3.24 | -11.67 | 4.98 | 5.10 | - |
| 2010 | 4.70 | 4.84 | 5.87 | 0.14 | -4.99 | -3.21 | -3.09 | 0.49 | 4.34 | 4.57 | 1.80 | 4.34 | +20.78% |
| 2011 | -4.93 | -0.52 | -1.71 | 3.48 | 3.28 | -1.57 | -1.16 | -13.41 | -0.17 | 1.99 | 4.08 | 6.82 | -5.27% |
| 2012 | 12.52 | -0.44 | 3.83 | 1.03 | 6.49 | 1.14 | 7.03 | -0.33 | 3.59 | -9.18 | 4.64 | -1.86 | +30.44% |
| 2013 | 4.47 | 5.61 | 9.77 | 6.55 | 4.77 | -4.15 | 12.35 | -2.03 | 6.33 | -3.56 | 8.10 | -0.15 | +57.85% |
| 2014 | 12.43 | 4.14 | -10.65 | -4.57 | 4.54 | 8.21 | 1.21 | 13.15 | 3.08 | 11.08 | 3.16 | 2.38 | +56.40% |
| 2015 | 15.76 | 6.41 | 5.03 | -7.83 | 12.31 | -1.95 | 2.94 | -12.77 | -11.98 | 10.68 | 7.11 | -1.84 | +20.78% |
| 2016 | -22.77 | -5.53 | -0.31 | 3.53 | 6.38 | -9.16 | 12.51 | -2.37 | 2.05 | -11.83 | 12.41 | -3.35 | -21.86% |
| 2017 | 4.94 | 9.09 | -1.11 | -0.06 | -6.83 | 6.01 | -0.54 | 3.80 | -0.35 | -4.44 | -1.11 | 0.28 | +8.95% |
| 2018 | 3.96 | -3.53 | -1.39 | -3.61 | 7.68 | 0.10 | 5.94 | 5.63 | -1.10 | -14.25 | 4.03 | -11.54 | -10.27% |
| 2019 | 12.67 | 5.10 | 2.40 | -6.48 | -3.73 | 6.89 | 0.76 | -2.04 | -2.51 | 4.16 | 12.68 | -0.50 | +31.13% |
| 2020 | -4.26 | -1.19 | -7.87 | 15.03 | 8.36 | 2.82 | -6.22 | -0.01 | 1.53 | -3.43 | 8.96 | 1.57 | +13.65% |
| 2021 | 5.20 | -2.30 | -2.42 | 1.70 | -0.50 | 8.23 | 3.09 | 2.54 | -3.99 | -0.04 | -1.26 | -0.69 | +9.28% |
| 2022 | -10.92 | -3.23 | 6.17 | -3.16 | -4.07 | 4.37 | 6.33 | -0.98 | 0.98 | 5.81 | 1.99 | -7.38 | -5.70% |
| 2023 | 0.39 | -4.44 | -1.27 | 0.39 | 1.46 | -2.81 | -0.69 | 0.46 | -1.61 | -6.73 | 0.43 | 0.98 | -12.94% |
| 2024 | 4.25 | 3.74 | 2.74 | -4.48 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 9.78% | 13.05% | 13.13% | 19.50% | 22.75% |
| Sharpe ratio | 1.90 | -0.11 | -0.62 | -0.28 | 0.05 |
| Best month | +4.25% | +4.25% | +4.25% | +8.23% | +15.03% |
| Worst month | -4.48% | -6.73% | -6.73% | -10.92% | -10.92% |
| Maximum loss | -4.48% | -7.76% | -15.50% | -27.23% | -29.19% |
| Outperformance | +9.79% | - | +8.56% | +2.82% | -7.56% |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Bellevue F.(L)-B.Obesity Sol.I2 ... | reinvestment | 161.0600 | -4.18% | -4.49% | |
| Bellevue F.(L)-B.Obesity Sol.I U... | reinvestment | 548.0900 | -6.99% | -15.69% | |
| Bellevue F.(L)-B.Obesity Sol.I E... | reinvestment | 688.9000 | -4.31% | -4.90% | |
| Bellevue F.(L)-B.Obesity Sol.I C... | reinvestment | 440.6400 | -5.50% | -16.00% | |
| Bellevue F.(L)-B.Obesity Sol.I G... | reinvestment | 465.3900 | -7.12% | -5.24% | |
| Bellevue F.(L)-B.Obesity Sol.B U... | reinvestment | 491.4700 | -7.64% | -17.44% | |
| Bellevue F.(L)-B.Obesity Sol.B C... | reinvestment | 393.0000 | -6.16% | -17.74% | |
| Bellevue F.(L)-B.Obesity Sol.B E... | reinvestment | 615.4700 | -4.98% | -6.87% |
Performance
| YTD | +6.13% | ||
|---|---|---|---|
| 6 Months | +1.22% | ||
| 1 Year | -4.31% | ||
| 3 Years | -4.90% | ||
| 5 Years | +27.22% | ||
| Since start | +451.12% | ||
| Year | |||
| 2023 | -12.94% | ||
| 2022 | -5.70% | ||
| 2021 | +9.28% | ||
| 2020 | +13.65% | ||
| 2019 | +31.13% | ||
| 2018 | -10.27% | ||
| 2017 | +8.95% | ||
| 2016 | -21.86% | ||
| 2015 | +20.78% | ||
